Sandesh Mahatme

Treasurer, Stalar 3 Inc.

Companies

Vor Biopharma Inc.Chief financial officer Jul 10, 2025 to now¹
CRISPR TherapeuticsBoard member May 30, 2024 to now²
Aeglea BioTherapeuticsBoard member Apr 6, 2016 to Jun 9, 2022³
Sarepta TherapeuticsChief financial officer Nov 7, 2012 to Jul 9, 2020⁴
Flexion TherapeuticsBoard member Jul 24, 2014 to Jun 12, 2020⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVor Biopharma Inc., Chief financial officer
2
SEC EDGARCRISPR Therapeutics, Board member
3
SEC EDGARAeglea BioTherapeutics, Board member
4
SEC EDGARSarepta Therapeutics, Chief financial officer
5
SEC EDGARFlexion Therapeutics, Board member